Skip to content

Research at St Andrews

Participatory governance over research in an academic research network: the case of Diabetes Action Canada

Research output: Contribution to journalArticle

Author(s)

Donald J Willison, Joslyn Trowbridge, Michelle Greiver, Karim Keshavjee, Doug Mumford, Frank Sullivan

School/Research organisations

Abstract

Digital data generated in the course of clinical care are increasingly being leveraged for a wide range of secondary purposes. Researchers need to develop governance policies that can assure the public that their information is being used responsibly. Our aim was to develop a generalisable model for governance of research emanating from health data repositories that will invoke the trust of the patients and the healthcare professionals whose data are being accessed for health research. We developed our governance principles and processes through literature review and iterative consultation with key actors in the research network including: a data governance working group, the lead investigators and patient advisors. We then recruited persons to participate in the governing and advisory bodies. Our governance process is informed by eight principles: (1) transparency; (2) accountability; (3) follow rule of law; (4) integrity; (5) participation and inclusiveness; (6) impartiality and independence; (7) effectiveness, efficiency and responsiveness and (8) reflexivity and continuous quality improvement. We describe the rationale for these principles, as well as their connections to the subsequent policies and procedures we developed. We then describe the function of the Research Governing Committee, the majority of whom are either persons living with diabetes or physicians whose data are being used, and the patient and data provider advisory groups with whom they consult and communicate. In conclusion, we have developed a values-based information governance framework and process for Diabetes Action Canada that adds value over-and-above existing scientific and ethics review processes by adding a strong patient perspective and contextual integrity. This model is adaptable to other secure data repositories.
Close

Details

Original languageEnglish
Article numbere026828
Number of pages9
JournalBMJ Open
Volume9
Issue number4
Early online date20 Apr 2019
DOIs
Publication statusPublished - Apr 2019

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Trial Forge Guidance 2: how to decide if a further Study Within A Trial (SWAT) is needed

    Treweek, S., Bevan, S., Bower, P., Briel, M., Campbell, M., Christie, J., Collett, C., Cotton, S., Devane, D., El Feky, A., Galvin, S., Gardner, H., Gillies, K., Hood, K., Jansen, J., Littleford, R., Parker, A., Ramsay, C., Restrup, L., Sullivan, F. & 7 others, Torgerson, D., Tremain, L., von Elm, E., Westmore, M., Williams, H., Williamson, P. R. & Clarke, M., 7 Jan 2020, In : Trials. 21, 9 p., 33.

    Research output: Contribution to journalArticle

  2. Choosing Wisely Canada campaign associated with less overuse of thyroid testing: retrospective parallel cohort study

    Wintemute, K., Greiver, M., McIsaac, W., Del Giudice, M. E., Sullivan, F., Aliarzadeh, B., Kalia, S., Meaney, C., Moineddin, R. & Singer, A., 13 Nov 2019, In : Canadian Family Physician. 65, 11, p. e487-e496

    Research output: Contribution to journalArticle

  3. The "All of Us" Research Program

    Sullivan, F., McKinstry, B. & Vasishta, S., 7 Nov 2019, In : New England Journal of Medicine. 381, 19, p. 1883-1885 3 p.

    Research output: Contribution to journalLetter

  4. Opioid agonist therapy during residential treatment of opioid use disorder: cohort study on access and outcomes

    Spithoff, S., Meaney, C., Urbanoski, K., Harrington, K., Que, B., Kahan, M., Leece, P., Shehadeh, V. & Sullivan, F., 11 Oct 2019, In : Canadian Family Physician. 65, 10, p. e443-e452 10 p.

    Research output: Contribution to journalArticle

  5. Effect on treatment adherence of distributing essential medicines at no charge: the CLEAN Meds randomized clinical trial

    Persaud, N., Bedard, M., Boozary, A. S., Glazier, R. H., Gomes, T., Hwang, S. W., Jüni, P., Law, M. R., Mamdani, M. M., Manns, B. J., Martin, D., Morgan, S. G., Oh, P. I., Pinto, A. D., Shah, B. R., Sullivan, F., Umali, N., Thorpe, K. E., Tu, K., Laupacis, A. & 1 others, for the Carefully Selected and Easily Accessible at No Charge Medicines (CLEAN Meds) Study Team, 7 Oct 2019, In : JAMA Internal Medicine. Online First

    Research output: Contribution to journalArticle

Related by journal

  1. A randomised, controlled, observer-masked trial of corneal cross-linking for progressive keratoconus in children: the KERALINK protocol

    Chowdhury, K., Dore, C., Burr, J. M., Bunce, C., Raynor, M., Edwards, M. & Larkin, D. F. P., 12 Sep 2019, In : BMJ Open. 9, 9, 6 p., e028761.

    Research output: Contribution to journalArticle

  2. Communication skills training for the radiotherapy team to manage cancer patients’ emotional concerns: a systematic review

    van Beusekom, M. M., Cameron, J., Bedi, C., Banks, E. & Humphris, G. M., 20 Apr 2019, In : BMJ Open. 9, 11 p., e025420.

    Research output: Contribution to journalReview article

  3. Protocol for the development of the STrengthening the Reporting of Pharmacogenetic Studies (STROPS) guideline: checklist of items for reporting pharmacogenetic studies

    Richardson, M., Kirkham, J. J., Dwan, K. M., Sloan, D. J., Davies, G. & Jorgensen, A., 11 Jul 2019, In : BMJ Open. 9, 7, 5 p., e030212.

    Research output: Contribution to journalArticle

  4. Simvastatin as a neuroprotective treatment for Parkinson's disease (PD STAT): protocol for a double-blind, randomised, placebo-controlled futility study

    Carroll, C. B., Webb, D., Stevens, K. N., Vickery, J., Eyre, V., Ball, S., Wyse, R., Webber, M., Foggo, A., Zajicek, J., Whone, A. & Creanor, S., 7 Oct 2019, In : BMJ Open. 9, 10, 11 p., e029740.

    Research output: Contribution to journalArticle

ID: 258699773

Top